Expansion in pain management remains a major opportunity.Postoperative and neuropathic pain treatments drive usage.Patients unable to swallow tablets benefit significantly. The Oral Transmucosal Drugs Market is poised for steady expansion, registering a projected CAGR of 6.6% from 2025 to 2031. The market is expected to grow from US$ XX million in 2024 to US$ XX million by 2031, reflecting...